Look to see it move tomorrow. They are marketing recently approved Veltassa for hyperkalemia. Astrazeneca had a competing product up for an NDA and received a CRL, which is good news for RLYP. RLYP was up AH, and should move even higher with potential for a buyout.
The hyperkalemia space is similar in some respects to the hyperphosphatemia space that KERX competes in. Both companies are candidates for buyouts in their respective markets.
straZeneca receives Complete Response Letter from US FDA for sodium zirconium cyclosilicate (ZS-9) for oral suspension for treatment of hyperkalaemia
PUBLISHED 27 May 2016
27 May 2016
AstraZeneca today announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for sodium zirconium cyclosilicate (ZS-9), the investigational medicine being developed for the treatment of hyperkalaemia (high potassium level in the blood serum) by ZS Pharma, a wholly-owned subsidiary of AstraZeneca.
The CRL refers to observations arising from a pre-approval manufacturing inspection. The FDA also acknowledged receipt of recently-submitted data which it has yet to review. The CRL does not require the generation of new clinical data. AstraZeneca and ZS Pharma are evaluating the content of the CRL and will work closely with the FDA to determine the appropriate next steps for the NDA.
AstraZeneca remains committed to the development of sodium zirconium cyclosilicate as a treatment option for patients with hyperkalaemia. Interactions are ongoing with other health authorities in the European Union and Australia, where sodium zirconium cyclosilicate is currently under separate regulatory review.
I am on the FDA email list, and got an email about it at 3PM Eastern time.
The best kind of manipulation is when you can use the truth to move a stock. The stock went down on the rumor, and then it went down when the rumor turned out to be true. This report could very well be true, but releasing it moves the stock. It it later turns out to be true then the stock may move again.
Retail in general has been getting killed. Macy's plunged today and took the rest of retail with it, including NKE.
When you are taking percentages, the absolute price of a stock does not matter.
Stock has been very good to me as well, but I got out on the last run up the the 27/28 area. It's been running up and then running down again and again. I'm waiting to see when things settle.
Making false claims to manipulate the price of a stock is a Federal crime, whether it works or not.
Given that this is in the mid-teens, a "rebound over 2.25" would not be particularly meaningful. Perhaps you meant something else?
Making a specific claim like "SEC halt" with the intention of manipulating the price (whether it works or not) is a Federal crime.
Google did something similar a while back. That is why Google (now Alphabet) has two tickers, GOOG and GOOGL. It was huge news, and Facebook is pretty much copying what they did.
Obviously meant "Google" not "Goggle". I blame auto-correct :)
It is similar to what Google did. The class C shares represent the same ownership as class A shares, but they will have no voting power. Goggle (now Alphabet) has two tickers, GOOG, and GOOGL. GOOG has no voting rights, while GOOGL shares do. The market therefore values GOOG slightly less than GOOGL, and the same is likely to be the case to the Class C versus Class A shares for Facebook.
Zuckerberg has class B shares, which have 10 votes per shares, versus 1 vote per share for A shares. Doing the split will allow him to use class C share as you say, but it will preserver the voting power of his B shares, which (if given away) would massively dilute his voting power.
You will not get B shares. You will get C shares. B shares have 10 votes per share and are held only by insiders, like Zuckerberg.
You get 2 class C shares for every Class A share. In effect, it acts like a 3 for 1 split, even though it is structured somewhat differently. The class A share will be worth 1/3 what it was and the class C shares each will be worth 1/3 of the current, but since you are getting 2 of them for each current class A share, they will make up the other 2/3 or the current value.
1/3 + 2/3 = 3/3 = 1. The value of your holdings does not change.
After the fact, the market may price the non-voting shares somewhat less.
Google did something similar a while back.